Werewolf joins pack of newly public biotechs with upsized $120M IPO
April 30, 2021 at 14:07 PM EDT
Listen for the howl: Cambridge oncology startup Werewolf Therapeutics has joined the public ranks, raising $120 million in an upsized initial public offering on Friday.
